A THERMAL SOURCE CENTER PIONEERING IN PROVIDING CARE
FOR CANCER PATIENTS
La Roche-Posay is the first thermal center in Europe exclusively dedicated to treating skin conditions. The centre offers a large selection of different treatments. In 2009, it shifted its focus to caring for skin affected by cancer treatments. A pioneer in this area, each year, the La Roche-Posay thermal center welcomes around 2300 patients requiring skincare due to the effects of cancer treatments.
Post-cancer thermal treatments are a new therapeutic approach for patients requiring skin and psychological recovery after their treatments. Two observational studies have demonstrated visible and lasting results in patients who have received a 3-week thermal treatment in the La Roche-Posay thermal station, with very good tolerance and high degrees of satisfaction when it comes to improved quality of life.
ESKIMO: AN EUROPEAN WORKING GROUP TO BETTER UNDERSTAND
THE IMPACTS ON SKIN OF CANCER TREATMENT
La Roche-Posay has brought together a working group composed of dermatologists and oncologists specialising in the dermatological problems associated with skin cancer treatments.
This working group, the European SKIn Management in Oncology (ESKIMO), has analysed and identified the various side effects of treatments and has proposed recommendations of suitable skincare products and make-up.
The laboratory has also worked alongside the Eskimo group to create an algorithm-guide* of best practices and products to limit and prevent the cutaneous side effects of cancer treatments.
A STAKEHOLDER
IN PROFESSIONAL TRAINING
Starting in 2013, La Roche-Posay has intensified its focus on the cutaneous side effects of cancer treatments. This commitment has given rise to a desire to bridge the gap between dermatology and oncology. La Roche-Posay endeavors to train and share its knowledge Thermal spring water about the cutaneous side effects of cancer treatments with healthcare professionals, including doctors, nurses, socio-aestheticians, and pharmacists.
In this way, La Roche-Posay contributes to training thousands of healthcare professionals worldwide and is involved in numerous partnerships with associations that teach patients how to best use products.
PRODUCTS ARE TESTED IN REAL-TIME
UNDER MEDICAL SUPERVISION
Within this approach of continual progress and research on adverse effects, La Roche-Posay has conducted many clinical studies and observational studies that establish that the products are well tolerated and have a positive impact on the cutaneous side effects of cancer treatments.
Born of thermal spring water that has therapeutic value and the expertise of sensitive skin specialists, the La Roche-Posay Dermatology Laboratory has become a close partner in caring for people who have cancer.
CORRECTIVE MAKEUP WORKSHOP:
CARE THAT PROVIDES REAL SUPPORT TO CANCER PATIENTS
The very first corrective makeup workshop was run in 1994 in the La Roche-Posay village, at the 1st European Thermal Center for Dermatology. This project aimed to improve patients’ quality of life during their cancer treatments. Learning corrective makeup techniques helps patients come to terms with their image and regain the self-confidence they need when battling cancer. These workshops are a place where patients can feel listened to, share experiences and learn. They help patients feel better, rebuild social relationships, and regain their pleasure in life.
The La Roche-Posay Dermatological Laboratory supports this initiative in two ways: by providing its high-tolerance makeup line Tolériane which includes pigment-rich products suitable for sensitive skin that are easy to apply and effective at concealing blemishes, and by funding new workshops worldwide. To date, 90 workshops have been launched worldwide.
"Algorithm for dermocosmetic use in the management of cutaneous side effects associated with targeted therapy in oncology" published by the prestigious Journal of the European Academy of Dermatology & Venereology and Breast Cancer.
